Qiagen NV (QGEN) Q1 2026 Earnings Call Highlights: Navigating Mixed Sales with Strong Profitability [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
Adjusted Diluted EPS: $0.54 at constant exchange rates, in line with outlook. Sample Technologies Sales: $170 million, up 9% CER. Diagnostic Solutions Sales: $185 million, down 4% CER. QuantiFERON Sales: Declined 5% CER. Adjusted Operating Income Margin: Approximately 27.4%. 2026 Net Sales Growth Outlook: Expected to grow about 1% to 2% CER. 2026 Adjusted Diluted EPS Outlook: At least $2.43 CER. Warning! GuruFocus has detected 2 Warning Signs with QGEN. Is QGEN fairly valued? Test your thesis with our free DCF calculator. Release Date: April 28, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Qiagen NV ( NYSE:QGEN ) delivered strong profitability with adjusted diluted EPS of $0.54, in line with their outlook despite mixed sales results. Four out of five growth pillars achieved or exceeded expectations, with Sample Technologies growing 9% at constant exchange rates (CER). QIAsupply del
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Qiagen (QGEN) had its price target lowered by JPMorgan Chase & Co. from $60.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
- Qiagen (QGEN) had its price target lowered by Citigroup Inc. from $55.00 to $38.00. They now have a "neutral" rating on the stock.MarketBeat
- Qiagen (QGEN) was given a new $38.00 price target by Barclays PLC.MarketBeat
- Qiagen (QGEN) was given a new $43.00 price target by Robert W. Baird.MarketBeat
- Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1 [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 2/4/26 - Beat
QGEN
Sec Filings
- 3/20/26 - Form 20-F
- 3/20/26 - Form IRANNOTICE
- 2/10/26 - Form SCHEDULE
- QGEN's page on the SEC website